Evidence map›Paper›PMID 15895268›Full record

ReviewEuropean journal of clinical pharmacology2005

"Medicamentation" of society, non-diseases and non-medications: a point of view from social pharmacology.

T B Ngoundo Mbongue, A Sommet, A Pathak, J L Montastruc

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of clinical pharmacology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Psychological drivers in doping: the life-cycle model of performance enhancement.Substance abuse treatment, prevention, and policy · 2008
    Article
  4. [Lifestyle drugs in medicine].Wiener medizinische Wochenschrift (1946) · 2008
    Review
  5. Article
  6. Social pharmacology: expanding horizons.Indian journal of pharmacology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

T B Ngoundo MbongueLaboratoire de Pharmacologie Médicale et Clinique, Unité de Pharmacoépidémiologie, IFR INSERM 126, EA 3696 Faculté de Médecine de Toulouse, France.
A Sommet
A Pathak
J L Montastruc

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review presents the definition and goals of "social pharmacology", a new branch of clinical pharmacology, investigating relationships between drugs and society through the example of "medicamentation", defined as the use of drugs for social problems previously not requiring drug utilisation (ageing, smoking cessation, vigilance troubles, sleep synchronisation, loss of libido, etc.). The involvement of the different "actors" from our society (patients, physicians, pharmaceutical industries, clinical pharmacologists, regulatory agencies, etc.) in this phenomenon is also discussed.

Indexed as

Drug TherapyLife StylePhysician's RoleAgingCommunity ParticipationDrug IndustryForecastingGovernment AgenciesHumansInternetPatient Education as TopicPharmacology, ClinicalSexual Dysfunctions, PsychologicalSmoking Cessation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.